Diabetes technology use in the Middle East and Southeast Asia: penetrance, challenges, and unmet needs
Authors' conclusion
The adoption of modern diabetes technology is critically low in these regions, reinforcing the existence of an interregional "technology gap". Improving outcomes for children and adolescents with type 1 diabetes not only relies on funding to promote equitable access but also support through culturally-adapted education for providers, patients, and their families.
Study context
- Population
- Healthcare professionals (HCPs) managing children and adolescents with diabetes in the Middle East, Southeast Asia and beyond, reached via major pediatric endocrine societiesresponses from 27 countries
- Participants
- 196 participants
- Outcome
- Diabetes technology penetrance
Methodological detailsmultinational, survey of healthcare professionals
- Multinational
- Survey of healthcare professionals
Main finding
As reported in the abstract
HCPs reporting CGM use in <5% of their patients
49.2%
HCPs reporting insulin pump use in <5% of their pediatric population
74.1%
Observational data: associations, not effects.
Further findings
Barriers and needs for adoption
- Lack of financial resources (principal barrier)
- >95%
- Simpler technology
- 53.3%
- Maintaining patient motivation
- 52.3%
- Deficits in provider training
- 47.2%
- Structured patient education
- 46.7%
Original publication
Diabetes technology use in the Middle East and Southeast Asia: penetrance, challenges, and unmet needs. Diabetes Res Clin Pract. Published 24 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →